Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 204
Selected: 0
NCT IDTitle
NCT04946903A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008
NCT01929070A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007
NCT00940680Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension
NCT07205900Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
NCT04252963Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)
NCT04829149Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
NCT01822340Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
NCT01127217Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension
NCT01573663A Drug-Drug Interaction Study of Ambroxol and Levodropropizine
NCT01037543Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects
NCT01455584Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors
NCT03713684Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
NCT02523547Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude
NCT06357910A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
NCT04204629Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects
NCT03744182A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
NCT01197001A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
NCT05024721Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
NCT03371849PK and Safety Study of HCP1102, HGP0813 and HGP1408
NCT01521455Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
NCT01463982Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies
NCT04820907Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
NCT03897868A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
NCT05462535An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet
NCT03479073Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation
NCT01448330A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin
NCT01775579Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium
NCT01447797A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin
NCT03372850Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations
NCT06438172A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension
NCT01638286Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects
NCT04762407A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903
NCT05711381Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function
NCT05949333Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy
NCT06518122A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers
NCT02026817Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg
NCT03770728Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea
NCT00986843Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)
NCT01093729A Study of HM11260C in Healthy Male Subject
NCT02057887Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)
NCT04654702Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.
NCT04324905Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers
NCT03666351Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
NCT01548157Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule
NCT01452451Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
NCT03826641A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects
NCT02057172Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
NCT05199129Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
NCT05191563A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.
NCT06858397A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease